Experiment: 6ZZF

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.3 mM [U-15N] SLURP-1	95% H2O/5% D2O	10 mM	4.7	AMBIENT bar	310	Bruker AVANCE III 800
2	2D 1H-1H NOESY	0.3 mM [U-15N] SLURP-1	95% H2O/5% D2O	10 mM	4.7	AMBIENT bar	310	Bruker AVANCE III 800
3	3D HNCO	0.3 mM [U-13C; U-15N] SLURP-1	95% H2O/5% D2O	10 mM	4.7	AMBIENT bar	310	Bruker AVANCE III 800
4	3D HNCA	0.3 mM [U-13C; U-15N] SLURP-1	95% H2O/5% D2O	10 mM	4.7	AMBIENT bar	310	Bruker AVANCE 700
5	3D HNCACB	0.3 mM [U-13C; U-15N] SLURP-1	95% H2O/5% D2O	10 mM	4.7	AMBIENT bar	310	Bruker AVANCE III 800
10	3D HN(CO)CA	0.3 mM [U-13C; U-15N] SLURP-1	95% H2O/5% D2O	10 mM	4.7	AMBIENT bar	310	Bruker AVANCE III 800
9	3D 1H-15N TOCSY	0.3 mM [U-15N] SLURP-1	95% H2O/5% D2O	10 mM	4.7	AMBIENT bar	310	Bruker AVANCE 700
8	3D HNHA	0.3 mM [U-15N] SLURP-1	95% H2O/5% D2O	10 mM	4.7	AMBIENT bar	310	Bruker AVANCE III 800
7	3D HCCH-TOCSY	0.3 mM [U-13C; U-15N] SLURP-1	100% D2O	10 mM	4.7	AMBIENT bar	310	Bruker AVANCE 700
6	2D 1H-13C HSQC	0.3 mM [U-13C; U-15N] SLURP-1	100% D2O	10 mM	4.7	AMBIENT bar	310	Bruker AVANCE 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	800
2	Bruker	AVANCE	700

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA	3.98.13	Guntert, Mumenthaler and Wuthrich
2	chemical shift assignment	CARA	1.8	Keller and Wuthrich
3	collection	TopSpin		Bruker Biospin
4	processing	MddNMR		V. Orekhov, V. Jaravine, M. Mayzel, K. Kazimierczuk, Swedish NMR Center, University of Gothenburg
5	peak picking	CARA		Keller and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.